Department of Psychology, University of Maryland, 4094 Campus Drive, College Park, Maryland, USA.
Department of Psychology, University of Miami, Miami, FL, USA.
AIDS Behav. 2022 Jan;26(1):102-115. doi: 10.1007/s10461-021-03354-1. Epub 2021 Jun 26.
There is a need for parsimonious behavioral interventions to support HIV and substance use treatment outcomes for low-income, Black/African American individuals living with HIV. This randomized clinical trial (N = 61) evaluated Act Healthy (AH), an integrated behavioral intervention to reduce substance use and improve medication adherence, compared to supportive counseling (SC) plus Life-Steps medication adherence counseling on substance use, craving, adherence-related outcomes, and depression over one year. Participants in AH had significantly steeper decreases in cravings compared to SC, but no significant differences in substance use. Across both groups, there was a significant increase in probability of being on antiretroviral therapy (ART) (86% on ART at 12 months vs. 56% at baseline), and a significant decrease in medication nonadherence. Findings provide preliminary support for an intervention to reduce cravings and strategies to improve ART use in a hard-to-reach, vulnerable population at high risk for poor treatment outcomes and ongoing HIV transmission. TRIAL REGISTRATION: ClinicalTrials.gov trial registration number: identifier: NCT01351454. Retrospectively registered on May 10, 2011.
需要采取简约的行为干预措施,以支持低收入、感染艾滋病毒的黑人/非裔美国人群体的艾滋病毒和药物使用治疗结果。这项随机临床试验(N=61)评估了 Act Healthy(AH),这是一种综合行为干预措施,旨在减少物质使用并提高药物依从性,与支持性咨询(SC)加 Life-Steps 药物依从性咨询相比,后者针对物质使用、渴望、与依从性相关的结果和抑郁进行了为期一年的研究。与 SC 相比,AH 组的渴望明显下降,但物质使用没有显著差异。在两组中,接受抗逆转录病毒治疗(ART)的概率都显著增加(12 个月时 86%的人接受 ART,而基线时为 56%),药物不依从性显著下降。这些发现为减少渴望和改善在难以接触的弱势群体中使用抗逆转录病毒治疗的策略提供了初步支持,这些人群处于治疗结果不佳和持续艾滋病毒传播的高风险之中。 试验注册:ClinicalTrials.gov 试验注册编号:标识符:NCT01351454。于 2011 年 5 月 10 日回顾性注册。
Appl Health Econ Health Policy. 2023-9
J Opioid Manag. 2020
Res Theory Nurs Pract. 2019-11-1
Biol Psychiatry. 2020-1-1
Addict Health. 2018-4